ICL Group Ltd
ICL Group Ltd (ICL) Financial Performance & Income Statement Overview
Analyze ICL Group Ltd (ICL) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
ICL Group Ltd (ICL) Income Statement & Financial Overview
View the income breakdown for ICL Group Ltd ICL across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.77B | $1.60B | $1.75B | $1.75B |
| Cost of Revenue | $1.21B | $1.07B | $1.16B | $1.18B |
| Gross Profit | $560.00M | $535.00M | $596.00M | $568.00M |
| Gross Profit Ratio | $0.32 | $0.33 | $0.34 | $0.32 |
| R&D Expenses | $18.00M | $19.00M | $19.00M | $14.00M |
| SG&A Expenses | $345.00M | $347.00M | $343.00M | $344.00M |
| Operating Expenses | $375.00M | $388.00M | $382.00M | $357.00M |
| Total Costs & Expenses | $1.58B | $1.45B | $1.54B | $1.54B |
| Interest Income | $25.00M | $0.00 | $7.00M | $26.00M |
| Interest Expense | $62.00M | $0.00 | $46.00M | $59.00M |
| Depreciation & Amortization | $151.00M | $157.00M | $140.00M | $152.00M |
| EBITDA | $361.00M | $251.00M | $362.00M | $389.00M |
| EBITDA Ratio | $0.20 | $0.16 | $0.21 | $0.22 |
| Operating Income | $185.00M | $147.00M | $214.00M | $211.00M |
| Operating Income Ratio | $0.10 | $0.09 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | -$37.00M | -$33.00M | -$38.00M | -$33.00M |
| Income Before Tax | $148.00M | $114.00M | $176.00M | $178.00M |
| Income Before Tax Ratio | $0.08 | $0.07 | $0.10 | $0.10 |
| Income Tax Expense | $42.00M | $33.00M | $49.00M | $48.00M |
| Net Income | $91.00M | $70.00M | $113.00M | $115.00M |
| Net Income Ratio | $0.05 | $0.04 | $0.06 | $0.07 |
| EPS | $0.07 | $0.06 | $0.09 | $0.09 |
| Diluted EPS | $0.07 | $0.06 | $0.09 | $0.09 |
| Weighted Avg Shares Outstanding | $1.29B | $1.29B | $1.29B | $1.29B |
| Weighted Avg Shares Outstanding (Diluted) | $1.29B | $1.29B | $1.29B | $1.29B |
Over the past four quarters, ICL Group Ltd demonstrated steady revenue growth, increasing from $1.75B in Q2 2024 to $1.77B in Q1 2025. Operating income reached $185.00M in Q1 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $361.00M, reflecting operational efficiency. Net income rose to $91.00M, with EPS at $0.07. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan